To view this email as a web page, click here.
October 25, 2018
 
Dermatology Times
Adverse pregnancy events not more common with secukinumab
For women with psoriasis, psoriatic arthritis, and ankylosing spondylitis who take secukinumab during pregnancy or conception, recent research shows adverse pregnancy events don't happen at a higher rate.
 
Women disproportionately affected by the psychological impact of skin diseases
Women in treatment for skin diseases, including psoriasis, experience higher levels of non-psychotic psychiatric disorders, including anxiety and depression, than men.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.